BOLD Market Cap History
Below is a table of the BOLD market cap history going back to 7/20/2016:

Date BOLD Market Cap

Also see: BOLD Shares Outstanding History
and BOLD YTD Return
BOLD Historical Market Cap:
+52.81% CAGR
BOLD Historical Market Cap: +52.81% CAGR

Mouse over chart for data details
7/20/2016 ...11/4/2019
Audentes Therapeutics is a clinical stage biotechnology company focused on developing and commercializing gene therapy products for patients living with serious, life-threatening rare diseases caused by single gene defects. Co. has a portfolio of product candidates, including AT132 for the treatment of X-Linked Myotubular Myopathy, AT845 for the treatment of Pompe disease, AT342 for the treatment of Crigler-Najjar Syndrome, and AT307 for the treatment of the CASQ2 subtype of Catecholaminergic Polymorphic Ventricular Tachycardia. Co. focuses on the treatment of rare diseases caused by single gene, or monogenic, defects in DNA that can be addressed using gene therapy. We show 15 historical shares outstanding datapoints in our BOLD shares outstanding history coverage, used to compute BOLD market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing BOLD market cap history over the course of time is important for investors interested in comparing BOLD's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of BOLD versus a peer is one thing; comparing BOLD market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like BOLD can fluctuate over the course of history. With this page we aim to empower investors researching BOLD by allowing them to research the BOLD market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for BOLD:
BOLD SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Audentes Therapeutics (BOLD) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

BPMC Market Cap History
BPTH Market Cap History
BRKR Market Cap History
BRLI Market Cap History
BSPM Market Cap History
BSTC Market Cap History
BSX Market Cap History
BUG Market Cap History
BUR Market Cap History
CAH Market Cap History
More Healthcare companies »


BOLD Market Cap History | | Copyright © 2017 - 2021, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.